We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) Poised for Earnings Growth: Time to Buy?
Read MoreHide Full Article
On Aug 9, 2016, Zacks Investment Research upgraded CME Group Inc. (CME - Free Report) to Zacks Rank #2 (Buy).
Why the Upgrade?
CME Group has been witnessing a rise in earnings estimates on the back of strong second-quarter 2016 results. This securities exchange reported earnings of $1.14 that surpassed the Zacks Consensus Estimate by 2.7%. Earnings improved 15.2% year over year on record average daily volumes.
In the second quarter, the company witnessed a rise in contract volumes across geographies. In Europe, volumes in five of the company’s product areas surged more than 20%, with the strongest growth in energy and equities. In Asia, energy and metal volumes soared more than 140% and 80%, respectively. Latin America also demonstrated growth on the back of higher energy volumes.
CME Group witnessed solid revenue growth as well as cost-control induced margin expansion and earnings improvement in the second quarter. Four out of the company’s six product lines registered more than 20% year-over-year increase in volume and transaction fee revenues. CME Group reported revenue growth of 11% in the second quarter.
Additionally, its open interest reached an all-time high of more than 116 million contracts. This reflects an increased reliance of market participants on CME Group.
During the second quarter, CME Group became the first exchange to offer swaptions clearing that will enable clients to obtain the greater operational and capital efficiencies from clearing. This is expected to help the company develop more specialized products going forward. Recently, the company also progressed with its initiatives to enhance Live Cattle futures markets with feedback from the cattle industry.
The Zacks Consensus Estimate for 2016 moved up 2.8% to $4.47 per share as 88% of the estimates were revised higher over the last 30 days. For 2017, 88% estimates were revised higher over the same time frame, which raised the Zacks Consensus Estimate by 2.8% to $4.82 per share.
CME Group is well positioned for growth supported by its diverse derivative product lines. Also, the launch of products and effective capital deployment strengthen the company. In addition, its increasing global presence and meaningful acquisitions raise optimism. The long-term earnings growth is pegged at 9.7%.
Investors interested in the finance sector can look for MarketAxess Holdings Inc. (MKTX - Free Report) , Allied World Assurance Company Holdings, AG (AWH - Free Report) and Argo Group International Holdings, Ltd. . All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7Best Stocks for the Next 30 Days. Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
CME Group (CME) Poised for Earnings Growth: Time to Buy?
On Aug 9, 2016, Zacks Investment Research upgraded CME Group Inc. (CME - Free Report) to Zacks Rank #2 (Buy).
Why the Upgrade?
CME Group has been witnessing a rise in earnings estimates on the back of strong second-quarter 2016 results. This securities exchange reported earnings of $1.14 that surpassed the Zacks Consensus Estimate by 2.7%. Earnings improved 15.2% year over year on record average daily volumes.
In the second quarter, the company witnessed a rise in contract volumes across geographies. In Europe, volumes in five of the company’s product areas surged more than 20%, with the strongest growth in energy and equities. In Asia, energy and metal volumes soared more than 140% and 80%, respectively. Latin America also demonstrated growth on the back of higher energy volumes.
CME Group witnessed solid revenue growth as well as cost-control induced margin expansion and earnings improvement in the second quarter. Four out of the company’s six product lines registered more than 20% year-over-year increase in volume and transaction fee revenues. CME Group reported revenue growth of 11% in the second quarter.
Additionally, its open interest reached an all-time high of more than 116 million contracts. This reflects an increased reliance of market participants on CME Group.
During the second quarter, CME Group became the first exchange to offer swaptions clearing that will enable clients to obtain the greater operational and capital efficiencies from clearing. This is expected to help the company develop more specialized products going forward. Recently, the company also progressed with its initiatives to enhance Live Cattle futures markets with feedback from the cattle industry.
The Zacks Consensus Estimate for 2016 moved up 2.8% to $4.47 per share as 88% of the estimates were revised higher over the last 30 days. For 2017, 88% estimates were revised higher over the same time frame, which raised the Zacks Consensus Estimate by 2.8% to $4.82 per share.
CME Group is well positioned for growth supported by its diverse derivative product lines. Also, the launch of products and effective capital deployment strengthen the company. In addition, its increasing global presence and meaningful acquisitions raise optimism. The long-term earnings growth is pegged at 9.7%.
CME GROUP INC Price and Consensus
CME GROUP INC Price and Consensus | CME GROUP INC Quote
Stocks to Consider
Investors interested in the finance sector can look for MarketAxess Holdings Inc. (MKTX - Free Report) , Allied World Assurance Company Holdings, AG (AWH - Free Report) and Argo Group International Holdings, Ltd. . All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7Best Stocks for the Next 30 Days. Click to get this free report >>